Incannex Included in the S&P/ASX 300 Index

On September 2nd, 2022, S&P Dow Jones Indices announced the changes in the S&P/ASX Indices, effective prior to the open of trading on Monday, September 19, 2022, as a result of the September quarterly review.

Mr Joel Latham, CEO and Managing Director of Incannex Healthcare said “Being listed in the index is a precursory investment condition for many domestic
and international investment institutions so we are excited for the possibilities this recognition may bring”.